---
$id: https://graph.org.ai/products/commodity/51183503
$type: Product
source: UNSPSC
code: "51183503"
title: "Etoformin"
class: "51183500"
classTitle: "Antidiabetic and hyperglycemic guanidines"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etoformin

**UNSPSC Code**: 51183503
**Class**: [Antidiabetic and hyperglycemic guanidines](Antidiabetic and hyperglycemic guanidines.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-diabetic agent with the molecular formula C8H19N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 630F8M4Q1D, chemically known as 1-butyl-2-ethylbiguanide but more generally known as etoformin, which bears US NIH Compound Identifier 170347. European Medicines Agency schedules etoformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07322MIG. Most nations, for tariff and trade purposes, schedule etoformin under HS 29252900 and SITC 51482. As of Q4 2014, ETOFORMIN remains US FDA's Preferred Term for this commodity. Etoformin bears US NLM identifiers UMLS ID C1880583 and NCI Concept Code C65589. SMILES: CCCCN=C(NCC)N=C(N)N.

